United States News All stories

Liquidia Corporation (NASDAQ:LQDA) reported preliminary, unaudited commercial performance metrics for its lead product YUTREPIA (treprostinil) inhalation powder for the fourth quarter and full year ended December 31, 2025.

Meta Platforms (NASDAQ:META) said Friday it has signed 20-year power purchase agreements to buy electricity from three Vistra Corp. nuclear plants in the U.S. Midwest and entered development partnerships with two companies pursuing small modular reactor technology, as Big Tech races to lock in reliable, long-term energy supplies for expanding artificial intelligence and data center operations.

Haemonetics Corp. (NYSE:HAE) announced Friday it has acquired Vivasure Medical Limited, a Galway-based pioneer in vessel closure technology, in a move that significantly broadens its reach into the $2.5 billion global vascular closure market.

Kezar Life Sciences (NASDAQ:KZR) announced Friday that the FDA has granted a formal Type C meeting for the first quarter of 2026, a move that could revive the clinical path for its lead asset, zetomipzomib, following months of regulatory uncertainty.

ChipMOS TECHNOLOGIES (NASDAQ:IMOS) reported a sharp rise in fourth-quarter revenue on Friday, as the specialized semiconductor packager benefits from a "perfect storm" of high-density memory demand and a strategic shift toward AI-related infrastructure.

Sanuwave Health (NASDAQ:SNWV) reported preliminary fourth-quarter revenue that reached an all-time high, as the medical device maker effectively navigated a volatile reimbursement landscape that has left many of its competitors in the wound-care sector reeling.

Taiwan Semiconductor Manufacturing Company (NYSE:TSM), the world's largest contract chipmaker, reported fourth-quarter revenue that rose 20.45% from the year-ago period on surging interest in artificial intelligence applications.

Mesoblast (NASDAQ:MESO) reported a breakout quarter for its flagship cellular medicine, Ryoncil, with sales jumping 60% to reach $35.1 million for the period ended December 31, 2025.

AnaptysBio (NASDAQ:ANAB) moved to dismantle a key legal pillar of GSK’s (NYSE:GSK) defense in the Delaware Chancery Court on Thursday, filing a motion to dismiss claims that the biotech "repudiated" its lucrative royalty agreement for the blockbuster-intent cancer drug Jemperli.

Appian Corp. (NASDAQ:APPN) announced it will pursue a second trial in its long-running trade secrets battle against Pegasystems (NASDAQ:PEGA0, following a Virginia Supreme Court ruling that refused to dismiss the case but sent it back to a lower court for a fresh look.

Johnson & Johnson (NYSE:JNJ) became the latest pharmaceutical titan to bow to White House pressure, announcing a voluntary agreement to lower prescription drug costs in exchange for an exemption from the administration’s aggressive new import tariffs.

ASE Technology Holding (NYSE:ASX) reported unaudited consolidated net revenues for December, the fourth quarter, and full year 2025.

December net revenues reached NT$58.865 billion, a 0.1% sequential increase and 11.3% higher year-over-year.

Nasa is ending an ISS mission early after one astronaut developed a serious medical condition.

Colombia’s president has warned of a real threat of US military action amid rising diplomatic tensions.

Iran’s internet blackout has sparked debate over whether bitcoin and other tools can still function without online access.

The US House approved a bill to extend healthcare subsidies, though its future in the Senate remains unclear.

French researcher Laurent Vinatier has been freed from Russia following a prisoner exchange with France.

Zelensky says Ukraine has yet to receive firm security guarantees from allies amid ongoing peace discussions with Russia.

Stablecoin payment flows could hit $56 trillion by 2030 as institutional and global adoption accelerates.

Florida is seeking to establish a standalone bitcoin reserve as lawmakers prepare for the 2026 legislative session.

BlackOpal is using blockchain to tokenise Brazilian credit card debt, giving merchants instant cash and investors double-digit returns.

Illicit crypto transactions hit a record in 2025 as sanctions pushed nation-states and blacklisted actors to move funds on-chain.

A revived New York bill aims to curb prediction markets covering sports, politics and death-related events.

Donald Trump has said he will not pardon former FTX chief executive Sam Bankman-Fried.